Vogel, Wolfgang

Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload

Zoller, H., Weiss, G., Theurl, I., Koch, R. O., Vogel, W., Obrist, P., Pietrangelo, A., Montosi, G., & Haile, D. J. (2001) · Gastroenterology

Iron Metabolism and DisordersTrace Elements in Health

Cited by 304

Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis

Zoller, H., Pietrangelo, A., Vogel, W., & Weiss, G. (1999) · The Lancet

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 167

Ferroportin disease: a systematic meta-analysis of clinical and molecular findings

Mayr, R., Janecke, A. R., Schranz, M., Griffiths, W. J. H., Vogel, W., Pietrangelo, A., & Zoller, H. (2010) · Journal of Hepatology

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 133

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Traussnigg, S., Schattenberg, J. M., Demir, M., Wiegand, J., Geier, A., Teuber, G., Hofmann, W. P., Kremer, A. E., Spreda, F., Kluwe, J., et al. (2019) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 88

Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency

Finkenstedt, A., Bianchi, P., Theurl, I., Vogel, W., Witcher, D. R., Wroblewski, V. J., Murphy, A. T., Zanella, A., & Zoller, H. (2009) · British Journal of Haematology

Iron Metabolism and DisordersGDF15 and Related Biomarkers

Cited by 51

Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease

Schaefer, B., Haschka, D., Finkenstedt, A., Petersen, B.-S., Theurl, I., Henninger, B., Janecke, A. R., Wang, C.-Y., Lin, H. Y., Veits, L., et al. (2015) · Human Molecular Genetics

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 35

Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio

Zoller, H., Schloegl, A., Schroecksnadel, S., Vogel, W., & Fuchs, D. (2012) · Journal of Interferon & Cytokine Research

Hepatitis C virus researchTryptophan and brain disorders

Cited by 33